Skip to main content
. 2020 Apr 20;46(6):1232–1242. doi: 10.1007/s00134-020-06029-y

Fig. 2.

Fig. 2

Semi-quantitative ESBL-E rectal (Panel 1) and throat (Panel 2) results for patients with VAP due to ESBL-E or not. ESBL-E extended spectrum beta-lactamase producing Enterobacterales, VAP ventilator-associated pneumonia